HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 75 filers reported holding HARROW HEALTH INC in Q3 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,528,541 | -55.5% | 315,140 | -41.1% | 0.00% | -66.7% |
| Q2 2023 | $10,184,720 | +8.8% | 534,976 | +20.9% | 0.00% | 0.0% |
| Q1 2023 | $9,362,348 | +305160.8% | 442,455 | +112.9% | 0.00% | +200.0% |
| Q4 2022 | $3,067 | -99.9% | 207,831 | +12.4% | 0.00% | 0.0% |
| Q3 2022 | $2,232,000 | +64.4% | 184,935 | -0.9% | 0.00% | – |
| Q2 2022 | $1,358,000 | +16.6% | 186,533 | +9.2% | 0.00% | – |
| Q1 2022 | $1,165,000 | -21.1% | 170,780 | 0.0% | 0.00% | – |
| Q4 2021 | $1,476,000 | -6.0% | 170,780 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $1,570,000 | -2.9% | 172,738 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,617,000 | +111.6% | 174,074 | +54.1% | 0.00% | – |
| Q1 2021 | $764,000 | +131.5% | 112,959 | +134.7% | 0.00% | – |
| Q4 2020 | $330,000 | +33.6% | 48,138 | +8.8% | 0.00% | – |
| Q3 2020 | $247,000 | +34.2% | 44,230 | +25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +139.0% | 35,375 | +159.5% | 0.00% | – |
| Q3 2019 | $77,000 | -54.2% | 13,633 | -29.4% | 0.00% | – |
| Q2 2019 | $168,000 | – | 19,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |